Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Roche”

Follow up to the AVANT Study up to 8 and 10 Years (Median Follow up) in Patients With Colon CarcinomaCompleted
NCT02228668N/AUpdated Feb 27, 2019
Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group
Colon Cancer Treated With Bevacizumab After Colon Surgery
France
Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With TrastuzumabTerminated
NCT00130507Phase 2Updated Feb 26, 2019
Sponsor: Spanish Breast Cancer Research Group
Breast Cancer
Spain
Monitoring of Multiple Sclerosis (MS) Participants With the Use of Digital Technology (Smartphones and Smartwatches) - A Feasibility StudyCompleted
NCT02952911NAUpdated Feb 22, 2019
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
United States, Spain
Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 TumoursTerminated
NCT00434941Phase 2Updated Feb 21, 2019
Sponsor: Spanish Breast Cancer Research Group
Breast Cancer
Spain
A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)Terminated
NCT02409355Phase 3Updated Feb 15, 2019
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
United States, Czechia, France, Germany, Greece +9 more
A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal CancerCompleted
NCT00483834Phase 2Updated Feb 15, 2019
Sponsor: University Health Network, Toronto
Colorectal Cancer
Canada
Tocilizumab for Patients With Giant Cell ArteritisCompleted
NCT01450137Phase 2Updated Feb 12, 2019
Sponsor: Insel Gruppe AG, University Hospital Bern
Giant Cell Arteritis
Switzerland
Retrospective Review of Proliferative Diabetic Retinopathy PatientsUnknown
NCT03609996N/AUpdated Feb 7, 2019
Sponsor: Elman Retina Group
Proliferative Diabetic Retinopathy
United States
Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young PatientsUnknown
NCT00863460Phase 2Updated Feb 5, 2019
Sponsor: Institut Curie
Primary Central Nervous System Lymphoma
France
Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant RecipientsTerminated
NCT01817699Phase 4Updated Feb 4, 2019
Sponsor: CANDLE-KIT Trial Study Group
Kidney Transplantation · Anemia · Vitamin D Deficiency · Renal Insufficiency, Chronic
Japan
Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .Completed
NCT02003703Phase 3Updated Jan 31, 2019
Sponsor: Universidad de Valparaiso
Hepatitis B · HIV
Chile
A Study of Adult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU])Completed
NCT03139513N/AUpdated Jan 22, 2019
Sponsor: Hoffmann-La Roche
Melanoma
France
Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast CancerCompleted
NCT01663727Phase 3Updated Jan 22, 2019
Sponsor: Hoffmann-La Roche
Metastatic Breast Cancer
United States, Argentina, Belgium, Brazil, Bulgaria +11 more
FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell LymphomaCompleted
NCT00530179NAUpdated Jan 22, 2019
Sponsor: AHS Cancer Control Alberta
Diffuse Large B Cell Lymphoma
Canada
A Translational Study of Bevacizumab in Participants With Metastatic Colorectal CancerCompleted
NCT01588990Phase 4Updated Jan 22, 2019
Sponsor: Hoffmann-La Roche
Colorectal Neoplasms
Australia
A Study to Assess the Efficacy of Rituximab (MabThera) in First Line Treatment of Chronic Lymphocytic Leukemia (CLL)Completed
NCT00545714Phase 2Updated Jan 16, 2019
Sponsor: Hoffmann-La Roche
Leukemia, Lymphocytic, Chronic, B-Cell
Spain
A Combined GWAS and miRNA for the Identification of Bevacizumab Response Predictors in Metastatic Breast CancerTerminated
NCT01598285N/AUpdated Jan 14, 2019
Sponsor: Spanish Breast Cancer Research Group
Breast Cancer Invasive Nos
Spain
A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.Completed
NCT01088659Phase 3Updated Jan 14, 2019
Sponsor: Hoffmann-La Roche
Hepatitis D, Chronic
Turkey (Türkiye)
Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells MaturationCompleted
NCT02569736N/AUpdated Jan 9, 2019
Sponsor: Association Aquitaine de Recherche Clinique en Rhumatologie
Arthritis, Rheumatoid · Tocilizumab · T-Lymphocytes, Helper-Inducer
France
BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian CancerCompleted
NCT01788995N/AUpdated Jan 3, 2019
Sponsor: Hoffmann-La Roche
Ovarian Cancer, Peritoneal Neoplasms
Austria
A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic StrokeTerminated
NCT02928393Phase 2Updated Jan 2, 2019
Sponsor: Hoffmann-La Roche
Stroke
France, Spain
Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) ParticipantsCompleted
NCT02187627Phase 1Updated Jan 2, 2019
Sponsor: Hoffmann-La Roche
Alzheimer's Disease, Healthy Volunteer
United States
Rituximab and Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients With Aggressive B-cell LymphomaCompleted
NCT01686321Phase 2Updated Dec 31, 2018
Sponsor: University of Göttingen
Aggressive Lymphoma
Germany
MabRella Study: A Study to Evaluate the Safety of Switching From Intravenous to Subcutaneous Administration of Rituximab During First-Line Treatment for LymphomaCompleted
NCT01987505Phase 3Updated Dec 26, 2018
Sponsor: Hoffmann-La Roche
Lymphoma, Non Hodgkin
Spain
A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic LeukemiaCompleted
NCT01292603Phase 1Updated Dec 19, 2018
Sponsor: Hoffmann-La Roche
Lymphocytic Leukemia, Chronic
Argentina, Australia, Brazil, Canada, Chile +14 more

Previous page Next page